Massive heart study aims to unlock secrets of cardiovascular disease
NCT ID NCT00406185
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a large registry that collects medical data and tissue samples from 30,000 people with heart disease and healthy volunteers. Researchers will analyze this information to better understand risk factors, treatments, and outcomes for various heart conditions. The goal is to improve future prevention and care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help identify new risk factors and improve treatments for heart disease.
- What could go wrong
- This is an observational registry, not a treatment trial, so it won't directly benefit participants. Results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 30,000 people
The number the study aims to enrol. It can still change while the study runs.
- Start date
-
Oct 1994
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All patients undergoing a procedure within the catheterization laboratory
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. The patient (male or non-pregnant female) must be \> 18 years of age. 2. The patient or legally authorized representative must sign a written informed consent, prior to the procedure, using a form that is approved by the local Institutional Review Board. Exclusion Criteria: 1. Neither patient nor patient representative understands spoken English. 2. Neither patient nor the patient's personal representative is willing to give written consent for participation. 3. Healthy control patients must sign their own consent document.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Intermountain Medical Center
Murray, Utah, 84157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart bypass surgeons test which vein layout keeps grafts open
- A soft patch that watches your heart beat in real time
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Zapping the ear: a new way to stop Post-Surgery heart rhythm problems?
- Squeeze a ball, lower your blood pressure? heart trial puts handgrip exercise to the test
- New heart scan aims to spot hidden plaque before it strikes